TickerFacts.

Precigen, Inc. (PGEN): Operating Income

Annual figures by period end, from SEC filings.

-$110.51M
Year ended 2025-12-31
-$39.50M
Trailing 12 months to 2026-06-30
2011-12-31: -$82.43M2012-12-31: -$75.16M2013-12-31: -$58.02M2014-12-31: -$69.96M2015-12-31: -$146.86M2016-12-31: -$125.17M2017-12-31: -$137.89M2018-12-31: -$505.61M2023-12-31: -$99.76M2024-12-31: -$135.03M2025-12-31: -$110.51M-$110.51M
2011-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$110.51Mn/m2026-03-25, From 2025-01-01
2024-12-31-$135.03Mn/m2026-03-25, From 2024-01-01
2023-12-31-$99.76Mn/a2026-03-25, From 2023-01-01
No annual figure between 2018-12-31 and 2023-12-31.
2018-12-31-$505.61Mn/m2019-03-01, From 2018-01-01
2017-12-31-$137.89Mn/m2019-03-01, From 2017-01-01
2016-12-31-$125.17Mn/m2019-03-01, From 2016-01-01
2015-12-31-$146.86Mn/m2018-03-01, From 2015-01-01
2014-12-31-$69.96Mn/m2017-03-01, From 2014-01-01
2013-12-31-$58.02Mn/m2016-02-29, From 2013-01-01
2012-12-31-$75.16Mn/m2015-03-02, From 2012-01-01
2011-12-31-$82.43Mn/a2014-03-31, From 2011-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Precigen, Inc. (PGEN)2025-12-31-$110.51Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31-$214.64Mn/m
Janux Therapeutics, Inc. (JANX)2025-12-31-$157.67Mn/m
Zenas BioPharma, Inc. (ZBIO)2025-12-31-$383.06Mn/m
International Stem Cell Corp (ISCO)2025-12-31-$267.0Kn/m
BioAge Labs, Inc. (BIOA)2025-12-31-$92.78Mn/m
Crescent Biopharma, Inc. (CBIO)2025-12-31-$152.63Mn/m
Roivant Sciences Ltd. (ROIV)2026-03-31-$515.07Mn/m
Jaguar Health, Inc. (JAGX)2025-12-31-$45.91Mn/m

Compare PGEN, PRTA, JANX, ZBIO side by side · Screen every company in Pharmaceutical Preparations ↗